Afatinib 20 mg, 30mg, 40 mg Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 20 mg, 30mg, 40 mg
Reference Brands: Gilotrif (USA), Giotrif (EU/UK)
Category: Oncology Cancer Care
Afatinib is a small-molecule tyrosine kinase inhibitor that irreversibly blocks signaling by the epidermal growth factor receptor (EGFR/ErbB) family (including EGFR, HER2, HER4). It is used primarily for adult patients with metastatic non-small-cell lung cancer (NSCLC) whose tumours harbour certain EGFR gene mutations, and also for squamous NSCLC progressing after platinum-based chemotherapy.
Afatinib — third party manufacturing & bulk supply
Afatinib 20 mg, 30mg, 40 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Afatinib listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Afatinib →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Afatinib is used for the treatment of non-small cell lung cancer (NSCLC) that has specific mutations in the epidermal growth factor receptor (EGFR) gene. It is also indicated for metastatic NSCLC and certain cases of squamous cell carcinoma of the lung. Afatinib helps block cancer cell growth by inhibiting EGFR and other related receptor tyrosine kinases.
Afatinib is made from the active ingredient afatinib dimaleate, which is an irreversible inhibitor of the ErbB family of receptors, including EGFR (ErbB1), HER2 (ErbB2), and HER4 (ErbB4).
The trade name of Afatinib is Gilotrif in the United States and Giotrif in the European Union and the United Kingdom.
Afatinib (Gilotrif/Giotrif) is developed and marketed by Boehringer Ingelheim Pharmaceuticals.
The generic name is Afatinib Dimaleate.
The brand names are Gilotrif and Giotrif.
Afatinib is manufactured by Boehringer Ingelheim at its facilities in Germany and the United States under strict international quality and regulatory standards.
Related Products
Fruquin 5 Mg (Fruquintinib)
Strength:
5 Mg
Form: Capsules
Reference Brands: Everest Bangladesh altd.
View Details
Vorinostat
Strength:
100 mg
Form: Capsules
Reference Brands: Zolinza (USA/EU), Vornat (India)
View Details
Panobinostat Lactate
Strength:
10 mg, 15 mg, 20 mg
Form: Capsules
Reference Brands: Farydak (USA/EU),
View Details
Gilteritinib
Strength:
40 mg
Form: Tablets
Reference Brands: Xospata (USA/India), LuciGil (Asia)
View DetailsQuick Response Guaranteed | Verified Suppliers
